10.1056/NEJMoa2413258 123 SargeantJ
Ivm Health is not affiliated with, endorsed by, or sponsored by these manufacturers
Beyond Ozempic: How Indian startups are building around GLP-1 drugs Even though India prohibits direct-to-consumer marketing of prescription drugs, regulators are watching out for messaging to induce misuse The first time Tushar Vashisht, co-founder and CEO of health and fitness app Healthify, tried taking a semaglutide-class weight-loss drug in 2024, it was solely to experience what it does to his metabolism
Gout There are some limited studies in patients with gout, some reporting a possible flare of gout when therapy with GLP1 is started, mostly due to rapid weight loss and dehydration that may precipitate gout attacks
The unit conversions for tirzepatide can be tricky, so using a reliable dosage calculator ensures accuracy
These three receptors working together create what pharmacologists call a synergistic metabolic cascade